Haptoglobin polymorphism, iron metabolism and mortality in HIV infection

被引:105
作者
Delanghe, JR
Langlois, MR
Boelaert, JR
Van Acker, J
Van Wanzeele, F
van der Groen, G
Hemmer, R
Verhofstede, C
De Buyzere, M
De Bacquer, D
Arendt, V
Plum, J
机构
[1] State Univ Ghent Hosp, Dept Clin Chem Microbiol & Immunol 1B2, B-9000 Ghent, Belgium
[2] Gen Hosp St Jan, Unit Renal & Infect Dis, Brugge, Belgium
[3] Inst Trop Med, B-2000 Antwerp, Belgium
[4] Ctr Hosp, Dept Infectiol, Luxembourg, Luxembourg
[5] State Univ Ghent Hosp, Dept Publ Hlth, B-9000 Gent, Belgium
关键词
haptoglobin; HIV; iron; ferritin; vitamin C; HIV-1; load; oxidative stress;
D O I
10.1097/00002030-199809000-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Three phenotypes of the antioxidant protein haptoglobin are known: Hp 1-1, Hp 2-1 and Hp 2-2. Objectives: To investigate the outcome of HIV infection according to haptoglobin type. Design and methods: Haptoglobin phenotypes were determined using starch gel electrophoresis in serum obtained from 653 HIV-infected Caucasians in the AIDS reference centers of Gent (n = 184), Antwerp (n = 309), and Luxembourg (n = 160). Survival was compared between haptoglobin types using Kaplan-Meier curves. Plasma HIV-1 RNA was quantified by reverse transcriptase PCR. Serum iron, transferrin saturation, ferritin, and vitamin C were assayed to evaluate iron-driven oxidative stress in 184 HIV-infected patients and 204 controls. Results: The haptoglobin type distribution amongst the patients (17.6% Hp 1-1, 49.9% Hp 2-1, 32.5% Hp 2-2) corresponded to that of the controls. Kaplan-Meier curves showed a higher mortality for the Hp 2-2 group (P = 0.0001; adjusted mortality risk ratio, 1.78; 95% confidence interval, 1.25-2.54). Median survival time was 11.0 years (Hp 1-1 and Hp 2-1) versus 7.33 years (Hp 2-2). Plasma HIV-1 RNA levels prior to antiviral therapy and their increase over 1 year were highest in Hp 2-2 patients (P = 0.03 and 0.003, respectively). The Hp 2-2 type was associated with higher serum iron, transferrin saturation, and ferritin levels and with low vitamin C concentrations. Furthermore, ferritin concentrations were higher in HIV-infected patients than in controls (P < 0.0001). Conclusion: HIV-infected patients carrying the Hp 2-2 phenotype show a worse prognosis, which is reflected by a more rapid rate of viral replication (in the absence of antiviral treatment). They also accumulate more iron and oxidize more vitamin C, suggesting that less efficient protection against haemoglobin/iron-driven oxidative stress may be a direct mechanism for stimulating viral replication. (C) 1998 Lippincott-Raven Publishers.
引用
收藏
页码:1027 / 1032
页数:6
相关论文
共 38 条
[1]   DETECTION OF LYMPHOCYTE SUBSETS USING 3-COLOR SINGLE-LASER FLOW-CYTOMETRY AND THE FLUORESCENT DYE PERIDININ CHLOROPHYLL-A PROTEIN [J].
AFAR, B ;
MERRILL, J ;
CLARK, EA .
JOURNAL OF CLINICAL IMMUNOLOGY, 1991, 11 (05) :254-261
[2]  
BEUTLER HO, 1984, METHOD ENZYMAT AN, V6, P376
[3]  
Boelaert JR, 1996, INFECT AGENT DIS, V5, P36
[4]   Iron and infection [J].
Boelaert, JR .
ACTA CLINICA BELGICA, 1996, 51 (04) :213-221
[5]   Conference report: International conference on HIV and iron, Brugge 1997 [J].
Boelaert, JR ;
Gordeuk, VR ;
Piette, J ;
Weinberg, GA .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (11) :1102-1106
[6]   Iron and oxidative stress as a mechanism for the enhanced production of human immunodeficiency virus by alveolar macrophages from otherwise healthy cigarette smokers [J].
Boelaert, JR ;
Piette, J ;
Weinberg, GA .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04) :1045-1046
[7]   Host factors and the pathogenesis of HIV-induced disease [J].
Fauci, AS .
NATURE, 1996, 384 (6609) :529-534
[8]  
FINK PC, 1989, J CLIN CHEM CLIN BIO, V27, P261
[9]   ASCORBATE IS AN OUTSTANDING ANTIOXIDANT IN HUMAN-BLOOD PLASMA [J].
FREI, B ;
ENGLAND, L ;
AMES, BN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (16) :6377-6381
[10]   Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500x10(6)/1 [J].
Garcia, F ;
Vidal, C ;
Gatell, JM ;
Miro, JM ;
Soriano, A ;
Pumarola, T .
AIDS, 1997, 11 (01) :53-57